Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Andrx To Modify Fortamet Promotional Materials Due To Similarity With Sankyo's WelChol

This article was originally published in The Pink Sheet Daily

Executive Summary

The company has offered to make "certain changes" to the Fortamet promotional materials following notification from Sankyo of potential confusion with WelChol's trademark. Andrx says it does not know the "ultimate outcome of this matter."

Andrx has offered to change its Fortamet (metformin extended-release) promotional materials due to similarities to Sankyo's WelChol (colesevelam) trademark.

"The company has offered to make certain changes to its promotional materials" for Fortamet "but is not in a position to determine the ultimate outcome of this matter," Andrx' Nov. 3 1 10-Q states.

In August 2004, Sankyo "notified Andrx that the promotional materials employed by Fortamet were confusingly similar to its registered trademark and the promotional materials employed by Sankyo's WelChol product," the 10-Q states.

Both the 2 Fortamet logo and the 3 WelChol logo have a nearly identical green and blue color scheme and each has a sweeping, color changing arrow pointing to the left side of the trademarks.

- John Rancourt

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS058113

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel